ACC Oklahoma Chapter 2020 Annual Scientific Meeting

Saturday, August 29, 2020, 7:45 AM - 1:00 PM


This annual one-day meeting is an exciting program that will highlight world-class faculty discussing up-to-date information about drugs and technologies that are indicated in a variety of common cardiovascular diseases. The content will be oriented toward the entire cardiac 
care team.  The educational objectives of the session will address the skills required of cardiovascular professionals for providing evidence based care to patients with cardiovascular disease.  The intimate format of this meeting will allow the audience to interact with invited speakers, network with colleagues from across the state and meet the cardiology fellows-in-training within the state.

1. Describe the imaging protocols for Tc-99m PYP imaging.
2. Discuss the strengths and weaknesses of the various imaging modalities.
3. Explain how to assess cardiac deformation with echo as a measure to be used beyond the global LVEF.
4. Apply Global Longitudinal Strain findings in a clinically meaningful manner in patients with AS and MR.
5. Discuss contemporary understanding of difficult clinical scenarios such as low flow low gradient or asymptomatic severe AS.
6. Review evidence base supporting current recommendations for DAPT after PCI.
7. Define the high bleeding risk phenotype and clinical trials examining short durations of DAPT in these patients.
8. Summarize key trials examining Aspirin withdrawal after PCI.
9. Examine existing approaches for use of triple therapy after PCI.
10. Identify the most recent recommendations from evidence-based guidelines for the treatment of venous thromboembolism.
11. Select the appropriate therapy for a patient with VTE.
12. Apply the recent evidence for the prevention of VTE in hospitalized medical patients at risk for VTE.

$25 ACC Members
$95 Non ACC Members
$25 ACC CCA Members
$0 Fellow in Training

Course fee includes CME credits.
Cancellations must be received in writing by August 14, 2020 in order to receive a full refund.
No refunds will be issued after August 14, 2020.

The University of Oklahoma College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The University of Oklahoma College of Medicine designates this live activity for a maximum of 3.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Conflict Resolution Statement:
The University of Oklahoma College of Medicine, Office of Continuing Professional Development has reviewed this activity’s speaker and planner disclosures and resolved all identified conflicts of interest, if applicable.

Nondiscrimination Statement:
The University of Oklahoma, in compliance with all applicable federal and state laws and regulations, does not discriminate on the basis of race, color, national origin, sex, sexual orientation, genetic information, gender identity, gender expression, age, religion, disability, political beliefs, or status as a veteran in any of its policies, practices or procedures. This includes, but is not limited to: admissions, employment, financial aid and educational services. Inquiries regarding non-discrimination policies may be directed to: Bobby J. Mason, Institutional Equity Officer, (405) 325-3546, [email protected], or visit www.ou.edu/eoo.

Accommodation Statement:
Accommodations on the basis of disability are available by contacting Beth Quick-Andrews, C.A.E., at (314) 416-2240 or [email protected] as soon as possible.

Acknowledgement of Commercial and In-Kind Support:
Commercial support is financial, or in-kind, contributions given by a commercial interest, which is used to pay all or part of the costs of a CME activity.  A commercial interest is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.

Appropriate acknowledgement of all commercial and in-kind support will be given at the time of the educational activity.

Disclaimer Statement:
Statements, opinions and results of studies contained in the program are those of the presenters and authors and do not reflect the policy or position of the Board of Regents of the University of Oklahoma (“OU”) nor does OU provide any warranty as to their accuracy or reliability.

Every reasonable effort has been made to faithfully reproduce the presentations and material as submitted. However, no responsibility is assumed by OU for any claims, injury and/or damage to persons or property from any cause, including negligence or otherwise, or from any use or operation of any methods, products, instruments or ideas contained in the material herein.

Policy on Faculty and Presenters Disclosure: 
It is the policy of the University of Oklahoma, College of Medicine that the faculty and presenters disclose real or apparent conflicts of interest relating to the topics of this educational activity, and also disclose discussions of unlabeled/unapproved uses of drugs or devices during their presentation(s).

AMA PRA Category 1 Credits™ (3.00 hours), Non-Physician Attendance (3.00 hours)

The registration form for this activity is currently unavailable.

Saturday, August 29, 2020

Acknowledgement of Commercial and In-Kind Support:
Commercial support is financial, or in-kind, contributions given by a commercial interest, which is used to pay all or part of the costs of a CME activity.  A commercial interest is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.

Appropriate acknowledgement of all commercial and in-kind support will be given at the time of the educational activity.